1 |
Emelianova AG, Petrova NV, Fremez C, Fontanié M, Tarasov SА, Epstein ОI. Therapeutic potential of highly diluted antibodies in antibiotic-resistant infection. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106161] [Reference Citation Analysis]
|
2 |
Hrdý J, Súkeníková L, Petrásková P, Novotná O, Kahoun D, Petříček M, Chroňáková A, Petříčková K. Inhibition of Pro-Inflammatory Cytokines by Metabolites of Streptomycetes-A Potential Alternative to Current Anti-Inflammatory Drugs? Microorganisms 2020;8:E621. [PMID: 32344935 DOI: 10.3390/microorganisms8050621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Khan F, Oloketuyi SF, Kim YM. Diversity of Bacteria and Bacterial Products as Antibiofilm and Antiquorum Sensing Drugs Against Pathogenic Bacteria. Curr Drug Targets 2019;20:1156-79. [PMID: 31020938 DOI: 10.2174/1389450120666190423161249] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
|
4 |
Guerra MES, Destro G, Vieira B, Lima AS, Ferraz LFC, Hakansson AP, Darrieux M, Converso TR. Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis. Front Cell Infect Microbiol 2022;12:877995. [DOI: 10.3389/fcimb.2022.877995] [Reference Citation Analysis]
|
5 |
Shankar U, Jain N, Mishra SK, Sharma TK, Kumar A. Conserved G-Quadruplex Motifs in Gene Promoter Region Reveals a Novel Therapeutic Approach to Target Multi-Drug Resistance Klebsiella pneumoniae. Front Microbiol 2020;11:1269. [PMID: 32714288 DOI: 10.3389/fmicb.2020.01269] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|